高原红细胞增多症藏族医诊疗专家共识  

Expert consensus on Tibetan medicine diagnosis and treatment for high altitude polycythemia

作　　者：高原红细胞增多症藏族医诊疗专家共识小组 仲格嘉 Expert Consensus Group of Tibetan Medicine Diagnosis and Treatment for High Altitude Polycythemia

机构地区：[1]不详

出　　处：《中国中药杂志》2024年第17期4805-4811,共7页China Journal of Chinese Materia Medica

基　　金：国家重点研发计划“中医药现代化”重点专项(2022YFC3501000)。

摘　　要：高原红细胞增多症是最常见的慢性高原病之一,是我国青藏高原地区突出的公共健康问题。藏族医(以下简称“藏医”)为高原红细胞增多症提供了安全有效的治疗方法,但目前尚无相应的藏医诊疗专家共识。该共识基于循证医学原则,参考中华中医药学会《中医药临床实践指南专家共识形成的技术规范》推荐的专家共识制定流程与方法,通过文献检索、专家访谈、临床调研和会议共识法确定5个临床问题,采用PICO原则[P(研究人群)、I(干预措施)、C(对照措施)、O(结局指标)]进行证据检索、筛选与综合,广泛征求国内各主要藏医医疗机构高原病和心脑血管疾病专家,以及部分中医、西医和循证医学专家的意见,通过1次专家共识会议和2轮德尔菲法专家问卷调查形成推荐意见及共识建议。共识包括疾病诊断、病因病机、辨证分型、临床治疗、结局评价、预防调护等内容。临床治疗方案包括藏医辨证论治、单方单药和外治疗法。各疗法均有相应的证据等级和推荐意见。该共识以临床问题为导向,辨病与辨证相结合,突出藏医的特色和优势,以期促进高原红细胞增多症藏医诊疗和研究的规范化,提高防治水平。High altitude polycythemia(HAPC)is one of the most common chronic high-altitude diseases and a prominent public health issue in the Qinghai-Xizang Plateau region of China.Tibetan medicine has provided a safe and effective treatment approach for HAPC,but there is currently no expert consensus on Tibetan medicine diagnosis and treatment for the disease.This consensus followed the principles of evidence-based medicine and learned the procedure and methods of Technical specifications on developing expert consensus for clinical practice guideline in traditional Chinese medicine recommended by China Association of Chinese Medicine.Five clinical issues were identified through literature search,expert interviews,clinical research,and conference consensus.The PICO principle was used for evidence retrieval,screening,and synthesis,and the opinions of experts on high-altitude diseases and cardiovascular and cerebrovascular diseases from major Tibetan medical institutions in China,as well as some traditional Chinese medicine(TCM),western medicine,and evidence-based experts,were widely solicited.Recommendations and consensus suggestions were formed through one expert consensus meeting and two rounds of Delphi expert questionnaire surveys.The consensus included disease diagnosis,etiology and pathogenesis,syndrome classification,clinical treatment,outcome evaluation,prevention and care,and other contents.Therapies for HAPC included Tibetan medicine treatments based on syndrome differentiation,single formula or patent medicine,and external treatment.Each treatment had corresponding levels of evidence and recommendations.This consensus was guided by solving clinical problems,combining disease diagnosis and syndrome differentiation and highlighting the characteristics and advantages of Tibetan medicine,with a view to promoting the standardization of Tibetan medicine diagnosis,treatment,and research on HAPC and improving the level of prevention and treatment.

关 键 词：高原红细胞增多症 藏族医 诊断 治疗 专家共识 

分 类 号：R29[医药卫生—民族医学]